EMARKET STORAGE - Teleborsa

DIASORIN SIMPLEXA™ COVID-19 TEST RECEIVED U.S. FDA 510(K) CLEARANCE

Protocollo

120181

Comunicato

20220914_120181.pdf

Azienda

DIASORIN

Tipo

Comunicato

SDIR

SDIRNIS

Lingua

ENG

Data creazione

Wed, 09/14/2022 - 02:30

Data ricezione SDIR

Wed, 09/14/2022 - 02:26

Data embargo SDIR

Wed, 09/14/2022 - 02:26

Data diffusione SDIR

Wed, 09/14/2022 - 02:27

Mercato

Euronext Milan